• Efficacy of Tree SLIT-tablet and Betula pendula pollen extract in adolescents (12‑17) with allergic rhinitis/rhinoconjunctivitis caused by birch pollen

    Not yet recruiting

    3 1
    France
  • Long-term Safety and Efficacy of ORKA-001 in Adults with Moderate-to-Severe Plaque Psoriasis (Open-Label Extension Study)

    Not yet recruiting

    2 1 1
    Germany Spain
  • Effect of antimicrobial drugs on tacrolimus and mycophenolate mofetil pharmacokinetics in kidney transplant recipients

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    Norway
  • Study of ivonescimab plus enfortumab vedotin versus pembrolizumab plus enfortumab vedotin in previously untreated locally advanced or metastatic urothelial carcinoma

    Not yet recruiting

    4 1 1 1
    Spain
  • Study of subcutaneous anifrolumab pharmacokinetics, pharmacodynamics and safety in children aged 5 to <18 years with systemic lupus erythematosus

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    Belgium Portugal
  • Long‑term Efficacy, Safety and Tolerability of maridebart cafraglutide in Adults with Obesity and Type 2 Diabetes

    Not yet recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria Czechia Germany Hungary Italy Poland
  • Efficacy and safety of ontunisertib in patients with fibrostenosing Crohn’s disease: a phase 2b randomized, double‑blind, placebo‑controlled dose‑ranging trial

    Not yet recruiting

    2 1
    Investigated Drugs:
    Belgium Czechia Denmark France Germany The Netherlands +1
  • Phase 3 Extension Trial Evaluating Long‑Term Efficacy, Safety and Tolerability of maridebart cafraglutide in Adults with Obesity

    Not yet recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Czechia Denmark Finland Germany Italy +1
  • Study of AZD6234 (lenbelintide) Added to Incretin Therapy in Adults with Obesity or Overweight and a Weight‑Related Comorbidity, With or Without Type 2 Diabetes

    Not yet recruiting

    3 1
    Investigated Drugs:
    Sweden
  • A Phase 3 Study of GSK5733584 with drug combination in patients with platinum‑resistant ovarian cancer

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    Austria Belgium Czechia Denmark Finland France +6

powered by